Sanford Burnham Prebys Medical Discovery Institute

Research facility

Location: La Jolla, CA / Orlando, FL, United States (USA) (US)

ISNI: 0000000101638573

ROR: https://ror.org/03m1g2s55

Show on Map:

Publications

(8)

A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression (2022) Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, et al. Journal article PROTEIN SURFACE SIGNATURE ON SERUM EXTRACELLULAR VESICLES FOR NON-INVASIVE DETECTION OF TUMOR PROGRESSION IN GLIOBLASTOMA PATIENTS (2021) Tzaridis T, Weller J, Bachurski D, Shakheri F, Schaub C, Hau P, Buness A, et al. Conference contribution Identification and Characterization of Dual-Acting Small Molecule Modulators targeting Secretin Receptors (2020) Dengler D, Sun Q, Kaleeckal H, Beutel J, Holleran J, Pollari S, Ma CT, et al. Conference contribution Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors (2020) Dengler DG, Sun Q, Holleran J, Pollari S, Beutel J, Brown BT, Iwaya AS, et al. Journal article Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018) Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, et al. Journal article ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer (2016) Strietz J, Stepputtis SS, Preca BT, Vannier C, Kim MM, Castro DJ, Au Q, et al. Journal article A Balance between B Cell Receptor and Inhibitory Receptor Signaling Controls Plasma Cell Differentiation by Maintaining Optimal Ets1 Levels (2014) Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, Müller J, Tedder T, et al. Journal article A balance between BCR and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels (2014) Luo W, Mayeux J, Gutierrez T, Getahun A, Müller J, Tedder T, Chen SH, et al. Journal article